Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

SHARON PERSONAL CARE TO INTRODUCE ECO-FRIENDLY WET WIPE PRESERVATIVE AT WORLD OF WIPES 2023

Sharon Personal Care

Sharon Personal Care, a global supplier of innovative, environmentally friendly ingredient solutions for a broad range of personal care products, will introduce the SharoWIPES™ line, the newest addition to the company’s groundbreaking wet wipe preservative platform. This new preservative is a clean label and eco-friendly solution that is free from phenoxyethanol, parabens, CIT/MIT, and formaldehyde donors. It offers a technological breakthrough that protects both the formula and the nonwoven from the outside environment. While developing its SharoWIPES line, Sharon Personal Care researched the impact of the physical characteristics of different types of fabrics, ranging from traditional to trendy, on preservation. Through systematic analysis of factors, such as contact angle, pore size, fiber diameter, and zeta potential, they gained valuable insights into the physical contributions affecting preservation. The interaction between microorganisms and fabrics was also thoroughly examined to enhance comprehension and proactively address preservation difficulties. “Preservation of wet wipes is known to be a very challenging issue. The unique product characteristics of wipes introduce microbiological risks for both the formula and the fabric, and ingredient safety concerns are especially high with wet wipes, since they are used for baby care and on sensitive areas,” says Paul Salama, PhD, Chief Technical Officer and Head of Innovation at Sharon Personal Care. “Our SharoWIPES line was created following in-depth research to address these challenges. The solutions in this line are optimized with carefully selected hydrophilic components that are combined with a unique anti-biofilm mechanism to deliver an ultimate level of protection for the wipe and formula.” SharoWIPES feature a carefully selected combination of hydrophilic elements, complemented by an antibiofilm agent. This breakthrough formulation ensures high efficacy and broad-spectrum protection at minimal usage levels. SharoWIPES not only prevents the formation of biofilms, which can harbor bacteria, but also addresses the selective interaction between preservatives and fabrics. By delivering optimal protection for both the formula and the non-woven fabric. Key features and benefits of SharoWIPES™ include: Broad spectrum protection against bacteria Unique anti-biofilm mechanism to prevent bacterial adherence High efficacy at low-usage levels (<l%) Flexible platform suitable for various wet wipe applications Water-soluble and readily biodegradable Globally compliant Odorless and colorless The preservative components in SharoWIPES are readily biodegradable, making them environmentally friendly. The entire range is vegan, ensuring its suitability for use on baby wipes and sensitive areas. All components of SharoWIPES have also been clinically tested for safety and some have an E number due to their inclusion in food additives listings. To learn more about SharoWIPES preservative platform, meet us at World of Wipes International Conference, taking place July 17-20 at the Atlanta Marriott Marquis in Georgia. Dr. Noa Ziklo from Sharon’s Innovation Group will also deliver a presentation, A Holistic Approach Towards Wipes Preservation, at World of Wipes on Wednesday, July 19 at 12:00 noon, and will share findings from the research Sharon conducted to develop its line of wet wipe preservatives. For those not attending World of Wipes, more information about SharoWIPES and Sharon Personal Care's full range of products can be found at https://sharonpc.com. SharoWIPES: Sharon Personal Care will introduce its new SharoWIPES™ line, the newest addition to the company's groundbreaking wet wipe preservative platform, during World of Wipes 2023. About Sharon Personal Care Headquartered in Ashdod, Israel, Sharon Personal Care is a global supplier of innovative ingredient solutions for a broad range of personal care products – with specialized expertise in trending market segments. The company’s product portfolio includes unique preservatives, building blocks, and functional chemistries and active ingredients. Today’s Sharon has a proven track record of innovation combined with the ability to provide comprehensive solutions at light speed. With a solid foundation in environmentally sustainable chemistry, Sharon delivers multifunctional ingredient solutions that help differentiate personal care products in a fast-changing market. Established in 1977 by Dr. Danny Sommerfeld, the company employs more than 200 people worldwide, with manufacturing and scientific facilities on three continents. Sharon Personal Care is owned primarily by Tene Investment Funds (Tel Aviv), an Israeli private equity growth fund focused on the industrial and technology sectors. Contact Details Resource Advantage Dan Green dgreen@resourceadvantage.com Sharon Personal Care Laura Mills, Business Development Manager laura@sharonpc.com Company Website https://sharonpc.com/

June 14, 2023 09:00 AM Eastern Daylight Time

Image

Negev Capital confident that big pharma will ultimately embrace psychedelics

Negev Capital

Negev Capital partner Ken Belotsky speaks to Thomas Warner from Proactive about the opportunities presented by the psychedelic startup scene. Belotsky describes the pharmaceutical market as "pretty conservative" overall, but says he believes that "soon we will see examples of M&A activity from big pharma into psychedelics, and as soon as it happens we will see a completely different [level of] interest from funds in the psychedelic space." The interview concludes with Belotsky discussing Negev Capital's sponsorship of the upcoming PSYCH symposium in London. Contact Details Proactive UK Ltd Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

June 14, 2023 03:56 AM Eastern Daylight Time

Video

Ananda Developments says cannabinoid-based medicine will become "completely ubiquitous"

Ananda Developments Plc

Ananda Developments (AQSE:ANA) co-founder and CEO Melissa Sturgess visits the Proactive London studio to speak with Thomas Warner about the work the cannabinoid medicine development company is doing to help develop treatments for patients suffering from complex, chronic inflammatory pain conditions. Sturgess says that cannabinoid-based medicine will ultimately become "completely ubiquitous" and highlights the various fronts that Ananda is currently pushing forward on, including two upcoming phase II randomised controlled clinical trials. Contact Details Proactive UK Ltd Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

June 14, 2023 03:46 AM Eastern Daylight Time

Video

Context Therapeutics shares #ASCO23 data on CLDN-6 targeted treatments and CTIM-76 update

Context Therapeutics

Context Therapeutics CEO Marty Lehr joins Natalie Stoberman from the Proactive studios to discuss the latest data on clinical cancer target Claudin 6 (CLDN6) presented at ASCO23 and how Context’s CTIM-76 CLDN6 X CD3 bispecific antibody sets itself apart from other CLDN6-targeted clinical candidates. Lehr says CLDN6 is differentially expressed on cancer cells with no or very low expression in normal, healthy adult tissue. CLDN6-enriched cancers include non-small cell lung (NSCLC), ovarian, testicular, and others. CTIM-76 is currently in preclinical development and is intended to direct activated immune T cells to CLDN6-expressing cancer cells. Preclinical studies of evaluating CTIM-76 demonstrates selective immune-mediated cell death of CLDN6-positive cancer cells. Contact Details Proactive Investors USA +1 347-449-0879 na-editorial@proactiveinvestors.com

June 13, 2023 01:34 PM Eastern Daylight Time

Video

News Release

Theralase Technologies shares positive interim results from Phase II Bladder Cancer study

Theralase Technologies Inc.

Theralase Technologies CEO Roger DuMoulin-White joined Steve Darling from Proactive to share interim data from a Phase II clinical study designed to treat patients diagnosed with Bacillus Calmette-Guérin Unresponsive, Non-Muscle Invasive Bladder Cancer and Carcinoma In-Situ with a patented investigational study drug Ruvidar, subsequently activated by a proprietary investigational study laser system equipped with fiber-optic light emitters and detectors. DuMoulin-White discussed more about the study and what the interim data is telling them about the study. He also talked about the company and the other vertical it has with its Cool Laser Therapy which is focused on the research, development, production and distribution of medical laser technologies for healing pain. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

June 13, 2023 01:30 PM Eastern Daylight Time

Video

Roberts and Ryan, Inc. Honors Laura Chan, Commander – Strategic Sealift Officer, U.S. Navy Reserves

Roberts & Ryan Investments, Inc.

Roberts & Ryan, Inc., America’s first Service-Disabled Veteran-Owned Broker Dealer, is proud to recognize Laura Chan for achieving the rank of Commander – as a Strategic Sealift Officer, U.S. Navy Reserves. On Tuesday, May 23, the Chief of Navy Reserve, Vice Admiral John Mustin, conducted her pinning ceremony at the New York Stock Exchange. Ms. Chan was accompanied by her close family, friends, and colleagues. “I’m very thankful for the village I have to support me in all of my endeavors,” said Ms. Chan. Ms. Chan has a 15+ year career in the U.S. Navy. Her last deployment was in support of Commander, U.S. 7th Fleet at Military Sealift Command (MSC) Far East as the Operational Support Officer located in Singapore. She is currently Vice President of Business Development at Roberts & Ryan, Inc., focusing on Equity Capital Markets, Pension Funds, and Corporate Development. She holds Series 7 & 63 licenses. “As of April 2023, the U.S. Navy Reserves contains 93,963 reservists that support commands located all over the world. Of the 93,000+ reservists, only 19 were selected to CDR in the Strategic Sealift Officer community and we're thrilled to have Laura as one of the 19 chosen,” said James McDevitt, Head of Equities Sales & Trading, Capital Markets at Roberts & Ryan, Inc. “Laura began her career at Roberts & Ryan as an intern in 2020, and she is one of the best examples of success in our social mission to help veterans in the area of career development. In the years since, she has proven herself to be a valuable member of our team. Her promotion to Commander is just one illustration of her dedication and work ethic, and I am proud to celebrate her accomplishment,” said Edward D’Alessandro, Chief Executive Officer of Roberts & Ryan, Inc. About Roberts and Ryan, Inc. Roberts & Ryan, Inc. is a Service-Disabled Veteran Owned (SDVO) broker-dealer with execution capabilities in the capital markets, equities, and fixed-income trading. The firm was founded in 1987 by a United States Marine Corps Vietnam combat veteran and Purple Heart recipient. With over $1.7 million dollars in committed donations, Roberts & Ryan is active in donating to charitable foundations that make significant positive impacts in the lives of Veterans and their families, primarily focusing on general wellness, mental health, and career transition. Contact Details Michael C. Del Priore +1 646-859-4061 mdelpriore@roberts-ryan.com Company Website https://www.roberts-ryan.com

June 13, 2023 09:00 AM Eastern Daylight Time

News Release

BullFrog AI revolutionizing precision medicine through artificial intelligence on bfLEAP platform

BullFrog AI

BullFrog AI CEO Vin Singh joins Natalie Stoberman from the Proactive newsroom to share how the company is using artificial intelligence (AI) for drug development through a renewed collaboration with Johns Hopkins Applied Physics Laboratory. Singh says BullFrog AI aims to reduce the time, costs, and risks associated with drug development by leveraging their bfLEAP proprietary AI platform. Singh explains the platform can identify new drug targets, provide insights, and help stratify patients for clinical trials in order increase the chances of success. Contact Details Proactive Investors +1 347-449-0879 na-editorial@proactiveinvestors.com

June 12, 2023 01:51 PM Eastern Daylight Time

Video

Father Boyle to Speak at The Chicago School’s SoCal Commencement

The Chicago School of Professional Psychology

Father Gregory Boyle, who has championed rehabilitation of former Los Angeles gang members for more than three decades, will be keynote speaker at The Chicago School of Professional Psychology’s Southern California commencement ceremony June 9, 2023 at the Long Beach Convention Center’s Terrace Theater. In recognition of his groundbreaking work educating, employing, and inspiring thousands of troubled youth and young adults, President Dr. Michele Nealon, Psy.D., will award Rev. Boyle a Doctor of Humane Letters, Honoris Causa. “We are honored to have Father Boyle speak to our 275 graduates about his life’s work rehabilitating individuals whom society have shunned,” said Dr. Nealon. “Father Boyle is the rare visionary who is passionate and practical—someone who is able to find solutions to what appear to be intractable problems.” Rev. Boyle was originally scheduled to speak at the 2020 commencement, which was cancelled due to the pandemic lockdown. Named a “Champion of Change” by former President Barack Obama in 2014, Rev. Boyle has been widely honored for his work, including receiving the Laetare Medal, the oldest honor given to American Catholics. A Los Angeles native, Rev. Boyle entered the Society of Jesus (Jesuits) immediately after graduating from Loyola High School in 1972. Over the next dozen years, he earned a bachelor's degree in English from Gonzaga University; a master’s in English from Loyola Marymount University; a Master of Divinity from the Weston School of Theology; and a Master of Sacred Theology from the Jesuit School of Theology, now part of Santa Clara University. From 1986 to 1992 Rev. Boyle served as pastor of Dolores Mission Church in Boyle Heights, Where he witnessed the devastating impact of gang violence during the “decade of death” that began in the late 1980s and peaked at 1,000 gang-related killings in 1992. In the face of law enforcement tactics and criminal justice policies of suppression and mass incarceration as the means to end gang violence, he and parish and community members adopted what was a radical approach at the time: treat gang members as human beings. In 1988 Rev. Boyle started what would eventually become Homeboy Industries, which employs and trains former gang members in a range of social enterprises. Homeboy now supports around 10,000 men and women a year, offering therapy, classes, services, job training, and employment at Homeboy Bakery, Homegirl Café, or Homeboy Silkscreen & Embroidery. At the center of it all is founder Rev. Boyle, who describes his work as “radical kinship,” accompanying those who come through Homeboy at virtually every step of their journeys at Homeboy and beyond. Rev. Boyle is the author of the 2010 New York Times -bestseller Tattoos on the Heart: The Power of Boundless Compassion. Other books he has written include Barking to the Choir: The Power of Radical Kinship, and The Whole Language: The Power of Extravagant Tenderness. “We are all invited into this exquisite mutuality where there is no us and them,” Rev. Boyle said. “Once we know that we are unshakably good and that we belong to each other, we can roll up our sleeves … and create anew this place of love and belonging that God would recognize.” About The Chicago School of Professional Psychology: Integrating theory with hands-on experience, The Chicago School of Professional Psychology provides education rooted in a commitment to innovation, service, and community for thousands of diverse students across the United States and globally. Founded in 1979, the nonprofit, regionally accredited university now features campuses in iconic locations across the country (Chicago, Southern California, Washington, D.C., New Orleans, Dallas) and online. To spark positive change in the world where it matters most, The Chicago School has continued to expand its educational offerings beyond the field of psychology to offer more than 30 degrees and certificates in the professional fields of health services, education, counseling, business, and more. Through its engaged professional model of education, commitment to diversity and inclusion, and an extensive network of domestic and international professional partnerships, The Chicago School’s students receive real-world training opportunities that reflect their future careers. The Chicago School is proud to be a part of TCS Education System, a nonprofit, integrated system of colleges and universities that works collaboratively to advance student success and community impact. To learn more, visit www.thechicagoschool.edu. Contact Details Vivien Hao +1 323-893-4743 vhao@thechicagoschool.edu

June 08, 2023 12:00 PM Pacific Daylight Time

News Release

AccuStem Sciences agrees to joint collaboration with University Hospitals

AccuStem

AccuStem Sciences Inc CEO Wendy Blosser joined Steve Darling from Proactive to share more details about the company that started as a spinout of Tiziana Life Sciences to focus on three primary healthcare verticals including pharmaceuticals, diagnostics or devices. The company’s main product is StemPrintER which is a 20-gene test using stem cells to predict cancer recurrence. Blosser telling Proactive more about the technology and where they see the biggest opportunities. One of those is a recent announcement that saw the company agree to a joint clinical collaboration agreement with University Hospitals. She says that agreement will provide tissue samples with clinical outcomes to AccuStem for research purposes. The agreement covers different cancers but will initially focus on breast cancer. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

June 08, 2023 02:10 PM Eastern Daylight Time

Video

1 ... 83 84 85 86 87 ... 267